Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say
admin Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized…
Read MoreHealthcare/Life Sciences
Investors piling into health-care ETFs points to defensive bets, ‘bottom-fishing’ in biotech
Hello! In this week’s ETF Wrap, health-care ETFs take the spotlight as investors get defensive…
Read MoreFDA approves Novavax’s COVID-19 vaccine for those 18 and older
U.S. health regulators have authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new…
Read MoreManchin, key to Democrats’ budget deal, sounds inflation alarm after hot CPI report
Sen. Joe Manchin, who’s key to congressional Democrats’ economic-policy efforts, on Wednesday sounded the alarm…
Read MoreWays to use tech in caring for an aging loved one, and apps that can help
This article is reprinted by permission from NextAvenue.org. Crystal Bailey, who lives in the Chicago…
Read MoreRamesh ‘Sunny’ Balwani former Theranos president found guilty on all 12 fraud charges
SAN JOSE, Calif.— A federal jury convicted Ramesh “Sunny” Balwani, the former top lieutenant to…
Read MoreThis strategist warned investors not to chase momentum at the top. Now he says it’s time to be a contrarian.
Michael Darda, chief economist and market strategist at MKM Partners, was no fan of the…
Read MoreA new kind of 55+ community is wooing residents with wellness, nature and cultural connections
In 2008, Janice Barton was vacationing at Serenbe, a biophilic, or nature-centered, community in the…
Read MoreMerck in talks to buy cancer biotech Seagen for about $40 billion
Merck & Co. MRK XE:MRK is in advanced talks to acquire Seagen Inc. SGEN and…
Read More
Caesars, SeaWorld downgraded on ‘waning’ confidence in ability to withstand looming recession
Shares of Caesars Entertainment Inc. and SeaWorld Entertainment Inc. slumped Wednesday after downgrades from KeyBanc…
Read More